152 related articles for article (PubMed ID: 25772200)
21. Transplantation of NIT-1 cells expressing pD-L1 for treatment of streptozotocin-induced diabetes.
Wen X; Zhu H; Li L; Li Y; Wang M; Liu J; Yang D; Liao W; Shen G
Transplantation; 2008 Dec; 86(11):1596-602. PubMed ID: 19077895
[TBL] [Abstract][Full Text] [Related]
22. B7-H4 transfection prolongs beta-cell graft survival.
Yuan CL; Xu JF; Tong J; Yang H; He FR; Gong Q; Xiong P; Duan L; Fang M; Tan Z; Xu Y; Chen YF; Zheng F; Gong FL
Transpl Immunol; 2009 Jul; 21(3):143-9. PubMed ID: 19361556
[TBL] [Abstract][Full Text] [Related]
23. Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses.
Kaner Z; Ochayon DE; Shahaf G; Baranovski BM; Bahar N; Mizrahi M; Lewis EC
J Infect Dis; 2015 May; 211(9):1489-98. PubMed ID: 25389308
[TBL] [Abstract][Full Text] [Related]
24. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.
Schowalter DB; Himeda CL; Winther BL; Wilson CB; Kay MA
J Virol; 1999 Jun; 73(6):4755-66. PubMed ID: 10233936
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.
Lu Y; Choi YK; Campbell-Thompson M; Li C; Tang Q; Crawford JM; Flotte TR; Song S
J Gene Med; 2006 Jun; 8(6):730-5. PubMed ID: 16518879
[TBL] [Abstract][Full Text] [Related]
26. Interaction of dendritic cells and T lymphocytes for the therapeutic effect of Dangguiliuhuang decoction to autoimmune diabetes.
Liu T; Cao H; Ji Y; Pei Y; Yu Z; Quan Y; Xiang M
Sci Rep; 2015 Sep; 5():13982. PubMed ID: 26358493
[TBL] [Abstract][Full Text] [Related]
27. Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus.
Elshikha AS; Lu Y; Chen MJ; Akbar M; Zeumer L; Ritter A; Elghamry H; Mahdi MA; Morel L; Song S
PLoS One; 2016; 11(5):e0156583. PubMed ID: 27232337
[TBL] [Abstract][Full Text] [Related]
28. The amelioration of composite tissue allograft rejection by TIM-3-modified dendritic cell: Regulation of the balance of regulatory and effector T cells.
Wang Y; Zheng Z; Zhu X; Han J; Dong M; Tao K; Wang H; Wang Y; Hu D
Immunol Lett; 2016 Jan; 169():15-22. PubMed ID: 26561949
[TBL] [Abstract][Full Text] [Related]
29. S-Nitrosylation of α1-Antitrypsin Triggers Macrophages Toward Inflammatory Phenotype and Enhances Intra-Cellular Bacteria Elimination.
Kaner Z; Engelman R; Schuster R; Rider P; Greenberg D; Av-Gay Y; Benhar M; Lewis EC
Front Immunol; 2019; 10():590. PubMed ID: 31001247
[No Abstract] [Full Text] [Related]
30. ECDI-fixed allogeneic splenocytes combined with α1-antitrypsin prolong survival of rat renal allografts.
Chen G; Li J; Chen L; Lai X; Qiu J
Int Immunopharmacol; 2015 May; 26(1):43-9. PubMed ID: 25749496
[TBL] [Abstract][Full Text] [Related]
31. Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties.
Lior Y; Zaretsky M; Ochayon DE; Lotysh D; Baranovski BM; Schuster R; Guttman O; Aharoni A; Lewis EC
Front Immunol; 2018; 9():759. PubMed ID: 29780379
[TBL] [Abstract][Full Text] [Related]
32. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
[TBL] [Abstract][Full Text] [Related]
33. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.
Koulmanda M; Bhasin M; Hoffman L; Fan Z; Qipo A; Shi H; Bonner-Weir S; Putheti P; Degauque N; Libermann TA; Auchincloss H; Flier JS; Strom TB
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16242-7. PubMed ID: 18852471
[TBL] [Abstract][Full Text] [Related]
34. Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression.
Wang X; Hao J; Leung G; Breitkopf T; Wang E; Kwong N; Akhoundsadegh N; Warnock GL; Shapiro J; McElwee KJ
J Immunol Res; 2015; 2015():607328. PubMed ID: 26000314
[TBL] [Abstract][Full Text] [Related]
35. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
36. Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells.
Mougel F; Bonnefoy F; Kury-Paulin S; Borot S; Perruche S; Kantelip B; Penfornis A; Saas P; Kleinclauss F
Diabetes Metab; 2012 Dec; 38(6):531-7. PubMed ID: 23182461
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
[TBL] [Abstract][Full Text] [Related]
38. Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice.
Lu Y; Tang M; Wasserfall C; Kou Z; Campbell-Thompson M; Gardemann T; Crawford J; Atkinson M; Song S
Hum Gene Ther; 2006 Jun; 17(6):625-34. PubMed ID: 16776571
[TBL] [Abstract][Full Text] [Related]
39. Alpha1-antitrypsin protects beta-cells from apoptosis.
Zhang B; Lu Y; Campbell-Thompson M; Spencer T; Wasserfall C; Atkinson M; Song S
Diabetes; 2007 May; 56(5):1316-23. PubMed ID: 17360983
[TBL] [Abstract][Full Text] [Related]
40. Differential signaling patterns of stimulated bone marrow-derived dendritic cells under α1-antitrypsin-enriched conditions.
Ozeri E; Rider P; Rigbi S; Shahaf G; Nita II; Sekler I; Lewis EC; Schuster R
Cell Immunol; 2021 Mar; 361():104281. PubMed ID: 33453508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
